Ablation Device Market Share Report | Size, Trends & Growth Outlook 2030
市场洞察和分析师观点:
消融是指通过手术切除器官、结构或部分。消融设备使用热量(通常由射频、射频、能量或激光产生)或极冷来造成轻微烧伤。推动消融设备市场增长的关键因素包括慢性病患病率的不断上升、老年人口的增加以及对微创手术的需求不断增加。然而,替代治疗方法和疗法的强势地位阻碍了市场增长。
增长动力和限制:
癌症、心血管疾病和呼吸系统疾病等慢性疾病的患病率不断上升,推动了全球消融设备市场的发展。消融手术为各种病症提供了有效的治疗选择,包括肿瘤消融、心律失常和肺部疾病。据世界卫生组织 (WHO) 统计,每年,非传染性疾病 (NCD) 是全球 4100 万人死亡的主要原因。此外,心血管疾病导致非传染性疾病死亡人数最多,每年有 1790 万人死亡,其次是癌症(930 万人)、慢性呼吸道疾病(410 万人)和糖尿病(200 万人,包括糖尿病引起的肾病死亡)。同样,根据美国国家癌症研究所 (NCI) 的数据,癌症正日益成为一个全球健康问题。 2020年,全球新增癌症病例超过1930万,导致约1000万人因癌症相关死亡。世界卫生组织估计,到 2040 年,全球每年可能会新增 2,890 万癌症病例,并导致约 1,620 万癌症相关死亡。慢性疾病负担的增加和对治疗方法的需求推动了对消融设备的需求。
此外,衰老是慢性疾病,特别是心血管疾病和癌症的重要危险因素。根据国际癌症控制联盟(UICC)的说法,衰老是癌症的一个重要危险因素,老年人的癌症发病率更高。根据世界卫生组织 (WHO) 的数据,2015 年至 2050 年间,世界 60 岁以上人口比例将增加近一倍,从 12% 增至 22%。根据 NCBI 2023 年 1 月发表的一项研究,美国到2050年,50岁及以上人口将达到22113万人,较2020年的13725万人迅速增加。50岁及以上人口预计患有至少一种慢性病,这一数字预计将从71.52增加99.5%预计到 2020 年,这一数字将达到 14266 万人,到 2050 年将达到 1.4266 亿。此外,预计到 2050 年,约有 1400 万人可能患有多种疾病。消融手术为老年人群提供了微创治疗选择,因为老年人群的手术风险可能较高。因此,老年人口的不断增加,加上慢性病的日益流行,推动了消融设备市场的增长。
然而,消融技术面临着来自替代治疗方法的竞争,包括手术干预、放射治疗、全身药物治疗、和其他微创手术。根据所治疗的具体病情,医疗保健提供者可能会根据疗效、安全性、患者资格、成本效益或资源可用性等因素选择替代治疗方式。替代治疗方案的可用性和偏好可能会限制消融装置的采用和使用。例如,由于公众对传统癌症治疗的认识较高,发展中国家对先进治疗方案的采用率较低,以及外科医生不愿放弃传统治疗方案,因此手术、化疗和放射治疗等治疗方法成为癌症治疗的首选。因此,上述因素阻碍了消融设备市场的增长。
报告细分和范围:
全球消融设备市场根据设备、应用和最终用户进行分类。根据设备,消融设备市场分为射频设备、激光/光消融设备、超声设备、冷冻消融设备等。根据用途,消融装置分为癌症治疗、心血管疾病治疗、眼科治疗、妇科治疗、泌尿外科治疗、美容外科治疗等。就最终用户而言,市场分为医院和诊所、门诊手术中心等。消融设备市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国) 、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷、以及南美洲和中美洲其他地区)。
细分分析:
消融设备市场按设备划分为射频设备、激光/光消融、超声设备、冷冻消融设备等。射频设备细分市场在 2022 年占据更大的市场份额,预计该细分市场在 2022 年至 2030 年期间将实现更高的复合年增长率。射频消融是一种微创手术,用于治疗肌瘤、骨骼、组织、甲状腺、子宫内膜、静脉曲张等。它是传统外科手术的替代方案。
消融设备市场,按设备划分 - 2022 年和 2030 年
消融设备市场,按应用划分,分为癌症治疗、心血管疾病治疗、眼科治疗、妇科治疗、泌尿外科治疗、整容手术等。 2022年,心血管疾病治疗领域占据更大的市场份额;此外,预计同一细分市场在 2022 年至 2030 年期间将出现更高的复合年增长率。
消融设备市场按最终用户划分,分为医院和诊所、门诊手术中心等。 2022 年,医院和诊所细分市场占据最大的市场份额,预计该细分市场在 2022 年至 2030 年期间复合年增长率最高。医院和诊所是消融设备的主要最终用户,因为它们提供广泛的医疗服务,包括需要消融的非侵入性手术。
区域分析:
根据地理位置,全球消融设备市场进行了细分分为五个主要区域:北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。据估计,2022 年至 2030 年亚太地区的复合年增长率最高。印度和中国等亚太国家拥有消融设备市场的巨大增长潜力。该地区的发展中国家改善了医疗基础设施,增加了医疗支出,并越来越注重采用先进的医疗技术,为市场扩张提供了机会。随着新兴市场对医疗保健基础设施的投资以及越来越多的医生接触到先进的消融技术,对消融设备的需求将会增加,从而推动亚太地区的市场增长。
北美在消融设备市场中占据最大份额2022年。2022年,美国在最大的消融设备市场中占据最大份额,并且在2022-2030年期间可能会继续这一趋势。据美国癌症协会估计,2021 年将有超过 190 万人被诊断出患有癌症,608,570 人因此死亡。此外,在美国,二分之一的男性和三分之一的女性可能在一生中被诊断出患有癌症。因此,癌症在人群中的高患病率推动了美国消融设备市场的增长。
根据美国医疗保险和医疗补助服务中心的数据,2021 年美国国家医疗保健支出增长了 2.7%,达到 100 亿美元每人 4.3 万亿美元或 12,914 美元。此外,医疗支出占全国国内生产总值(GDP)的18.3%。根据美国卫生与公众服务部的数据,2019 年至 2028 年期间,国家卫生支出预计将以每年 5.4% 的速度增长,到 2028 年将达到 6.2 万亿美元。医疗保健支出的增加可能会导致医疗保健资金增加与药物相关的研究和开发研究,刺激了学术界对消融设备的需求。
行业发展和未来机遇:
消融领域的技术进步显着提高了手术的有效性和安全性。较新的消融设备采用了射频、微波、冷冻消融和激光等先进技术,可实现精确的组织破坏,同时最大限度地减少对周围健康组织的损害。这些进步提高了成功率并扩大了消融手术的范围,推动了市场增长。下面列出了全球消融设备市场主要参与者采取的各种举措:
下面提到了全球消融设备市场的一些最新发展:
2023 年 5 月,雅培 (Abbott) 收到了美国食品和药物管理局的批准其 TactiFlex 消融导管(传感器启用)获得 (FDA) 批准,该产品成为世界上第一款采用柔性尖端和接触力技术的消融导管。2023 年 2 月,Hologic Inc. 的 NovaSure V5 全球子宫内膜消融 (GEA) 设备获得批准用于加拿大和欧洲的医疗用途。这一创新版本结合了增强的功能,可治疗广泛的宫颈和子宫解剖结构。 2021 年 11 月,美敦力印度公司在该国推出了 Arctic Front 心脏冷冻消融导管系统,用于治疗房颤 (AF)。该系统用于执行微创冷冻球囊导管消融术,这是用于治疗 AF 的治疗方式之一。2021 年 1 月,美敦力公司 (Medtronic plc) 的 DiamondTemp 消融 (DTA) 系统获得 FDA 批准,该系统适用于治疗复发性、有症状的患者阵发性房颤,特别是对传统药物无反应的患者。 DTA 是首个经 FDA 批准的温控、金刚石灌注射频 (RF) 消融系统,目前可用于进行消融。 2020 年 12 月,Acutus Medical 在欧洲推出了 AcQBlate 力感应消融系统。该产品是在 AcQBlate Force 消融导管和 Qubic 力传感模块获得 CE 标志后推出的。该消融系统中包含的 AcQBlate Force 是市场上唯一市售的金尖、冲洗、力感应射频消融导管。该系统还集成了 Acutus Medical 与 BIOTRONIK 的国际联盟提供的两个最先进的组件——Qubic RF 和 Qiona 灌溉泵。 2020 年 11 月,Abbott 宣布推出 IonicRF Generator,这是一款经 IonicRF Generator 批准的设备。 FDA 将提供一种非手术、微创治疗方法来治疗神经系统疼痛。这种射频消融设备利用热量瞄准特定神经并阻止疼痛信号到达大脑。该设备目前已获准在美国和欧洲销售。竞争格局和主要公司:
Abbott Laboratories、AngioDynamics Inc、AtriCure Inc、Biotronik、Boston Scientific Corporation、Conmed Corporation、Johnson and Johnson、Medtronic PLC、Olympus Corporation、和施乐辉公司 (Smith & Nephew PLC) 是消融设备市场的知名参与者。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的产品范围。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The ablation device market, by device, is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. The radiofrequency devices segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030.
The ablation device market, by application, is segmented into cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. The cardiovascular disease treatment segment held a larger market share in 2022; also, the same segment is anticipated to register a higher CAGR during 2022-2030.
Key factors driving the ablation device market growth include the growing prevalence of chronic diseases, an increase in the geriatric population, and increasing demand for minimally invasive procedures.
The ablation device market majorly consists of the players, including Abbott Laboratories, AngioDynamics Inc, AtriCure Inc, Biotronik, Boston Scientific Corporation, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, and Smith & Nephew PLC.
Ablation refers to the surgical removal of an organ, structure, or part. Ablation devices use heat (usually generated by radio frequency, RF, energy, or a laser) or extreme cold to cause minor burns.
The ablation device market was valued at US$ XX.XX million in 2022.
The ablation device market is expected to be valued at US$ XX.XX million in 2030.
The ablation device market, by end users, is segmented into hospitals and clinics, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022–2030.
The List of Companies - Ablation Device Market
- Abbott Laboratories
- AngioDynamics, Inc.
- AtriCure, Inc.
- Biotronik
- Boston Scientific Corporation
- Conmed Corporation
- Johnson and Johnson
- Medtronic PLC
- Olympus Corporation
- Smith & Nephew PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.